Story
Kalaris Therapeutics Stock Slides 6.4% Despite Naming Veteran Analyst as New CFO

Shares of Kalaris Therapeutics Inc. (NASDAQ:KLRS) fell on Monday, even as the company announced the appointment of a seasoned biotechnology analyst as its new Chief Financial Officer. The stock closed the session down 6.4% following the news.
Executive Appointment
Kalaris named Liisa Bayko its new CFO, bringing over 20 years of biotechnology finance experience to the clinical-stage company. The appointment was announced Monday.
Bayko most recently served as Managing Director and Senior Biotechnology Analyst at Evercore ISI, where her coverage focused on small- and mid-cap biotechnology companies. Her prior experience includes senior analyst roles at JMP Securities and positions at Prudential Equity Group and Baker Brothers Advisors.
Andrew Oxtoby, President and CEO of Kalaris, said in a statement that Bayko has extensive experience in valuing biotechnology companies, engaging with the investor community, and navigating capital markets.
AdMarket Context and Clinical Pipeline
The negative market reaction was notable given the appointment of an executive with a strong industry background. The leadership change comes as Kalaris continues to advance its lead product candidate, TH103.
The company is currently enrolling patients in a Phase 1b/2 study of TH103 for treatment-naïve neovascular age-related macular degeneration (wet AMD). Kalaris is focused on developing treatments for retinal diseases.
According to the company, TH103 is an investigational dual-targeting biologic designed for intravitreal delivery. Its potential applications also include other retinal conditions such as diabetic eye disease and retinal vein occlusion.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.